Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2

Molecular and Cellular Biochemistry

Volumn 274, Issue 1-2, 2005, Pages 85-90

  Allende Vega, Nerea ^a   Dias, Sylvia ^a   Milne, Diane ^a   Meek, David ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

CK2; DNA damage; Mdm2; p53; Phosphorylation

Indexed keywords

4,5,6,7 TETRABROMO 2 AZABENZIMIDAZOLE; CASEIN KINASE II; PROTEIN KINASE INHIBITOR; PROTEIN MDM2; PROTEIN P21; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TUMOR SUPPRESSOR GENE; UBIQUITINATION;

CASEIN KINASE II; CELL LINE; HUMANS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT FUSION PROTEINS; SERINE; SIGNAL TRANSDUCTION; TRIAZOLES; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 22344451422     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-3074-4     Document Type: Article

References (22)

1. Michael D, Oren M: The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13: 49-58, 2003. 12507556
2. Vousden KH, Lu X: Live or let die: The cell's response to p53. Nature Rev Cancer 2: 594-604, 2002
3. Argentini M, Barboule N, Wasylyk B: The contribution of the acidic domain of MDM2 to p53 and MDM2 stability. Oncogene 20: 1267-1275, 2001. 11313871
4. Kawai H, Wiederschain D, Yuan Z-M: Critical contribution of the MDM2 acidic domain to p53 ubiquitination. Mol Cell Biol 23: 4939-4947, 2003. 12832479
5. Meulmeester E, Frenk R, Stad R, de Graaf P, Marine J-C, Vousden KH, Jochemsen AG: Critical role for a central part of Mdm2 in the ubiquitylation of p53. Mol Cell Biol 23: 4929-4938, 2003. 12832478
6. Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP: An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19: 2312-2323, 2000. 10822382
7. Ganguli G, Wasylyk B: P53-independent functions of Mdm2. Mol Cancer Res 1: 1027-1035, 2003. 14707286
8. Blattner C, Hay TJ, Meek DW, Lane DP: Hypophosphorylation of Mdm2 augments p53 stability. Mol Cell Biol 22: 6170-6182, 2002. 12167711
9. Winter M, Milne D, Dias S, Kulikov R, Knippschild U, Blattner C, Meek D: Protein kinase CK1-delta phosphorylates key sites in the acidic domain of Mdm2 that regulate p53 turnover. Biochemistry 43: 16356-16364, 2004. 15610030
10. Litchfield DW: Protein kinase CK2: Structure, regulation and role in cellular decisions of life and death. Biochem J 369: 1-15, 2003. 12396231
11. Meggio F, Pinna LA: One thousand and one substrates of protein kinase CK2? FASEB J 17: 349-368, 2003. 12631575
12. Pinna LA: Protein kinase CK2: A challenge to canons. J Cell Sci 115: 3873-3878, 2002. 12244125
13. Keller DM, Zeng X, Wang Y, Zhang QH, Kapoor M, Shu H, Goodman R, Lozano G, Zhao Y, Lu H: A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell 7: 283-292, 2001. 11239457
14. Ghavidel A, Schultz MC: TATA binding protein-associated CK2 transduces DNA damage signals to the RNA polymerase III transcriptional machinery. Cell 106: 575-584, 2001
15. Maldonado E, Allende JE: Phosphorylation of yeast TBP by protein kinase CK2 reduces its specific binding to DNA. FEBS Lett 443: 256-260, 1999. 10025943
16. Burch L, Scott M, Pohler E, Meek D, Hupp T: Phage-peptide display identifies the death-activated protein kinase family as a novel modifier of the p53-inducible gene products MDM2 and p21WAF1. J Mol Biol 337: 115-128, 2004. 15001356
17. Kurki S, Peltonen K, Kiviharju T, Latonen L, Ojala P, Meek D, Laiho M: Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5: 465-475, 2004. 15144954
18. Gotz C, Kartarius S, Scholtes P, Nastainczyk W, Montenarh M: Identification of a CK2 phosphorylation site in mdm2. Eur J Biochem 266: 493-501, 1999. 10561590
19. Hjerrild M, Milne D, Dumaz N, Hay T, Issinger OG, Meek D: Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells. Biochem J 355: 347-356, 2001. 11284721
20. Sarno S, Moro S, Meggio F, Zagotto G, Dal Ben D, Ghisellini P, Battistutta R, Zanotti G, Pinna LA: Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol Ther 93: 159-168, 2002. 12191608
21. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A, Shugar D, Pinna LA: Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett 496: 44-48, 2001. 11343704
22. Leveillard T, Wasylyk B: The Mdm2 C-terminal region binds TAFII250 and is required for Mdm2 regulation of the cyclin A promoter. J Biol Chem. 272: 30651-30661, 1997. 9388200